Gemini Bioproducts, LLC, a supplier of cell culture reagents and process liquids, a portfolio company of BelHealth Investment Partners, LLC, launched new products designed to improve cell therapy manufacturing processes.   Unlike traditional biomanufacturing processes where there are extensive downstream purification steps after the initial cell culture process, cell therapy manufacturing has limited purification prior to patient administration. As such and given that the cultured cells for ce...